COMBINATIONS OF A MEK INHIBITOR COMPOUND WITH AN HER3/EGFR INHIBITOR COMPOUND AND METHODS OF USE

摘要

The invention provides combinations comprising a MEK inhibitor (such as GDC-0973 or GDC-0623), or a pharmaceutically acceptable salt thereof and a HER3/EGFR inhibitor (such as MEHD7945A). The combinations are particularly useful for treating hyperproliferative disorders, such as cancer.